Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients (original) (raw)

References

• Banks, R. E., Forbes, M. A., Kinsey, S. E., Stanley, A., Ingham, E., Walters, C. & Selby, P. J. (1998). Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956–964.
  Article CAS Google Scholar
• Blay, J. Y., Negrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J. M., Moskovtchenko, J. F. & Philip, T. (1992). Serum levels of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 52: 3317–3322.
  CAS PubMed Google Scholar
• Bousvaros, A., Zurakowski, D., Fishman, S. J., Keough, K., Law, T., Sun, C. & Leichter, A. M. (1997). Serum basic fibroblast growth factor in pediatric Crohn’s disease. Implications for wound healing. Dig Dis Sci 42: 378–386.
  Article CAS Google Scholar
• Brekken, R. A., Huang, X., King, S. W. & Thorpe, P. E. (1998). Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res 58: 1952–1959.
  CAS PubMed Google Scholar
• Bross, D. A., Leichtner, A. M., Zurakowski, D., Law, T. & Bousvaros, A. (1996). Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn’s disease. J Pediatr Gastroenterol Nutr 23: 164–171.
  Article CAS Google Scholar
• Clarke, D., Johnson, P. W. M., Banks, R. E., Storr, M., Kinsey, S. E., Johnson, R., Morgan, G., Gordon, M. Y., lllingworth, J. M., Perren, T. J. & Selby, P. J. (1996). Cytokine 8: 717–723.
  Article CAS Google Scholar
• Cohen, T., Nahari, D., Weiss Cerem, L., Neufeld, G. & Levi, B. (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736–741.
  Article CAS Google Scholar
• Degeorges, A., Tatoud, R., Fauvel-Lafeve, F., Podgorniak, M-P, Millot, G., De Cremoux, P. & Calvo, F. (1996). Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer 68: 207–214.
  Article CAS Google Scholar
• Duensig, S., Grosse, J. & Atzpodien, J. (1995). Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients. Anticancer Res 15: 2331–2334.
  Google Scholar
• Dvorak, H. F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650–1659.
  Article CAS Google Scholar
• Dirix, L. Y., Vermeulen, P. B., Hubens, G., Benoy, I., Martin, M., De Pooter, C. & Van Oosterom, A. T. (1996). Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7: 843–848.
  Article CAS Google Scholar
• Dirix, L. Y., Vermeulen, P. B., Pawinski, A., Prové, A., Benoy, I., De Pooter, C., Martin, M. & Van Oosterom, A. T. (1997). Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76: 238–243.
  Article CAS Google Scholar
• Dosquet, C., Coudert, M-C, Lepage, E., Cabane, J. & Richard, F. (1997). Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?. Clin Cancer Res 3: 2451–2458.
  CAS PubMed Google Scholar
• Ferriere, J. P., Bernard, D., Legros, M., Chassagne, J., Chollet, P., Gaillard, G. & Plagne, R. (1985). β-Thromboglobulin in patients with breast cancer. Am J Hematol 19: 47–53.
  Article CAS Google Scholar
• Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82: 4–6.
  Article CAS Google Scholar
• Gasparini, G. (1996). Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies. Eur J Cancer 32A: 2379–2385.
  Article CAS Google Scholar
• Handagama, P. J., Shuman, M. A. & Bainston, D. F. (1987). Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest 84: 73–82.
  Article Google Scholar
• Harrison, P., Wilbourn, B., Debili, N., Vainchenker, W., Breton-Gorius, J., Lawrie, A. S., Masse, J-M, Savidge, G. F. & Cramer, E. M. (1989). Uptake of plasma fibrogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 84: 1320–1324.
  Article CAS Google Scholar
• Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F. & Akiyama, Y. (1989). Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244.
  CAS PubMed Google Scholar
• Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. (1973). Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52: 2745–2756.
  Article CAS Google Scholar
• Kaushansky, K. (1995). Thrombopoietin: the primary regulator of platelet production. Blood 86: 419–431.
  CAS PubMed Google Scholar
• Kumar, H., Heer, K., Lee, P. W. R., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J. & Monson, J. R. T. (1998). Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4: 1279–1285.
  CAS PubMed Google Scholar
• Lake, A. M., Stauffer, J. Q. & Stuart, M. J. (1978). Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis 23: 897–902.
  Article CAS Google Scholar
• Liotta, L. A. & Saidel, G. M. (1974). Quantitative relationship of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997–1004.
  CAS PubMed Google Scholar
• Mateo, R. B., Reichner, J. S. & Albina, J. E. (1994). Interleukin-6 activity in wounds. Am J Physiol 266: R1840–1844.
  CAS PubMed Google Scholar
• Milroy, R., Douglas, J. T., Campbell, J., Carter, R., Lowe, G. D. & Banham, S. W. (1988). Abnormal haemostasis in small cell lung cancer. Thorax 43: 978–981.
  Article CAS Google Scholar
• Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L. & Rafii, S. (1997). Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94: 663–668.
  Article Google Scholar
• Møller Pedersen, L. M. & Milman, N. (1996). Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9: 1826–1830.
  Article Google Scholar
• Motro, B., Itin, A., Sachs, L. & Keshet, E. (1990). Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 87: 3092–3096.
  Article CAS Google Scholar
• Nakano, T., Chaninian, A. P., Shinjo, M., Tonomura, A., Miyake, M., Togawa, N., Ninomiya, K. & Higashino, K. (1998). Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 77: 907–912.
  Article CAS Google Scholar
• Rak, J. W., Hegmann, E. J., Lu, C. & Kerbel, R. S. (1994). Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. J Cell Physiol 159: 245–255.
  Article CAS Google Scholar
• Rak, J., Filmus, J. & Kerbel, R. S. (1996). Reciprocal paracrine interactions between tumour cells and endothelial cells: ‘angiogenesis progression’ hypothesis. Eur J Cancer 32A: 2438–2450.
  Article CAS Google Scholar
• Ravoet, C., De Grève, J., Vandewoude, K., Kerger, J., Sculier, J-P, Lacor, P., Stryckmans, P. & Piccart, M. (1994). Tumour stimulating effects of recombinant human interleukin-6. Lancet 344: 1576–1577.
  Article CAS Google Scholar
• Salven, P., Teerenhovi, L. & Joensuu, H. (1997). A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin’s lymphoma. Blood 90: 3167–3172.
  CAS PubMed Google Scholar
• Salven, P., Ruotsalainen, Mattson, K. & Joensuu, H. (1998). High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer. Int J Cancer 79: 144–146.
  Article CAS Google Scholar
• Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S. & Fusenig, N. E. (1997). Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 11: 1222–1227.
  Article Google Scholar
• Vadhan-Raj, S., Murray, L. J., Bueso-Ramos, C., Patel, S., Reddy, S. P., Hoots, W. K., Johnston, T., Papadopoulos, N. E., Hittelman, W. N., Johnston, D. A., Yang, T. A., Paton, V. E., Cohen, R. L., Hellmann, S. D., Benjamin, R. S. & Broxmeyer, H. E. (1997). Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med 126: 731–3.
  Article Google Scholar
• Verheul, H. M. W., Hoekman, K., Luykx-de Bakker, S., Eekman, C. A., Folman, C. C., Broxterman, H. J. & Pinedo, H. M. (1997). Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3: 2187–2190.
  CAS PubMed Google Scholar
• Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCulloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L. & Dirix, L. Y. (1996). Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474–2484.
  Article CAS Google Scholar
• Vermeulen, P. B., Dirix, L. Y., Martin, M., Lemmens, J. & Van Oosterom, A. T. (1997). The predictive value of serum bFGF and VEGF in patients with metastatic renal cell carcinoma treated with interferon α-2b. J Natl Cancer Inst 89: 1317
  Article Google Scholar
• Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristimäki, A., Heikinheimo, M., Joensuu, H., Alitalo, K. & Palotie, A. (1998). Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80: 171–175.
  Article CAS Google Scholar
• Weber, J., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H. & Cole, D. (1993). Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11: 499–506.
  Article CAS Google Scholar
• Yazaki, T., Inage, H., Iizumi, T., Koyama, A., Kanoh, S., Koiso, K., Narita, M. & Tojo, S. (1987). Studies on platelet function in patients with prostatic cancer. Preliminary report. Urology 30: 60–63.
  Article CAS Google Scholar
• Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang J Fuller, G., Brett, J., May, L. & Stern, D. (1995). Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. J Biol Chem 270: 11463–11471.
  Article CAS Google Scholar

Download references